CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Cheng, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Cheng, X.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, May 2006, p. 594-597, Vol. 13, No. 5
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.5.594-597.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Production of an Anti-Severe Acute Respiratory Syndrome (SARS) Coronavirus Human Monoclonal Antibody Fab Fragment by Using a Combinatorial Immunoglobulin Gene Library Derived from Patients Who Recovered from SARS

Jinye Liu,1 Hongxia Shao,1 Yanlin Tao,1 Bin Yang,1 Lisheng Qian,1 Xiaoli Yang,2 Brian Cao,3,4 Gengxi Hu,2 Hiroshi Tachibana,4* and Xunjia Cheng1,4

Department of Medical Microbiology and Parasitology, Fudan University School of Medicine,1 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China,2 Van Andel Research Institute, Grand Rapids, Michigan,3 Department of Infectious Diseases, Tokai University School of Medicine, Isehara, Japan4

Received 27 July 2005/ Returned for modification 17 October 2005/ Accepted 24 February 2006

A combinatorial human immunoglobulin gene library was constructed from the peripheral lymphocytes of two patients who recovered from severe acute respiratory syndrome (SARS). The library was screened for the production of Fab antibody fragments to a recombinant spike protein of SARS-associated coronavirus (SARS-CoV). One Fab clone, AS3-3, reacted with the spike protein in an enzyme-linked immunosorbent assay. The dissociation constant of AS3-3 was 1.98 x 10–8 M. Immunofluorescent microscopy revealed that it reacted with SARS-CoV-infected cells. The library seems to be a potent tool for the production of human antibodies to SARS-CoV.


* Corresponding author. Mailing address: Department of Infectious Diseases, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan. Phone: 81 (463) 93-1121. Fax: 81 (463) 95-5450. E-mail: htachiba{at}is.icc.u-tokai.ac.jp.


Clinical and Vaccine Immunology, May 2006, p. 594-597, Vol. 13, No. 5
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.5.594-597.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.